Treace Announces Participation in the Bank of America 2023 Healthcare Conference
April 26 2023 - 4:15PM
Treace Medical Concepts, Inc. (“Treace” or the “Company”)
(NasdaqGS: TMCI), a medical technology company driving a
fundamental shift in the surgical treatment of hallux valgus
(commonly known as bunions) through its Lapiplasty® 3D Bunion
Correction™ Procedure, today announced that John T. Treace, Chief
Executive Officer, and Mark L. Hair, Chief Financial Officer, will
participate in a fireside chat at the Bank of America 2023
Healthcare Conference on Wednesday, May 10, 2023, beginning at
approximately 11:40 am ET.
A live webcast and replay of the fireside chat
will be available on the Company’s investor relations website at
https://investors.treace.com/.
About Treace Medical Concepts
Treace Medical Concepts, Inc. is a medical
technology company with the goal of advancing the standard of care
for the surgical management of bunion and related midfoot
deformities. Bunions are complex 3-dimensional deformities that
originate from an unstable joint in the middle of the foot and
affect approximately 65 million Americans, of which Treace
estimates 1.1 million are annual surgical candidates. Treace has
pioneered and patented the Lapiplasty® 3D Bunion Correction™ System
– a combination of instruments, implants, and surgical methods
designed to surgically correct all 3 planes of the bunion deformity
and secure the unstable joint, addressing the root cause of the
bunion and helping patients get back to their active lifestyles.
Treace expanded its offering with the Adductoplasty® Midfoot
Correction System, designed for reproducible surgical correction of
the midfoot to provide further support to hallux valgus patients.
For more information, please visit www.treace.com.
Contacts:
Treace Medical ConceptsMark L. HairChief
Financial Officermhair@treace.com(904) 373-5940
Investors:
Gilmartin GroupLynn Lewis or Vivian
CervantesIR@treace.com
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Apr 2024 to May 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From May 2023 to May 2024